WallStreetZenWallStreetZen

NASDAQ: IFRX
Inflarx Nv Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IFRX

Based on 5 analysts offering 12 month price targets for Inflarx Nv

Min Forecast
$6.00+187.08%
Avg Forecast
$9.00+330.62%
Max Forecast
$14.00+569.86%

Should I buy or sell IFRX stock?

Based on 5 analysts offering ratings for Inflarx Nv.

Strong Buy
Strong Buy
3 analysts 60%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IFRX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates IFRX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their IFRX stock forecasts and price targets.

IFRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-14
lockedlocked$00.00+00.00%2026-08-07
lockedlocked$00.00+00.00%2026-05-13Find Out Why
lockedlocked$00.00+00.00%2026-05-11
lockedlocked$00.00+00.00%2026-04-21

1 of 1

Forecast return on equity

Is IFRX forecast to generate an efficient return?

Company
-39.87%
Industry
21.25%
Market
168.71%
IFRX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IFRX forecast to generate an efficient return on assets?

Company
-34.92%
Industry
23.75%
IFRX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IFRX earnings per share forecast

What is IFRX's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$0.28
Avg 2 year Forecast
-$0.35
Avg 3 year Forecast
-$0.46

IFRX revenue forecast

What is IFRX's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

IFRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IFRX$2.09$9.00+330.62%Strong Buy
VNDA$5.13$16.00+211.89%Strong Buy
FATE$2.53$6.38+151.98%Buy
QTTB$10.54$38.00+260.53%Strong Buy
ABEO$5.57$22.00+294.97%Strong Buy
View Top Biotech Stocks

Inflarx Nv Stock Forecast FAQ

Is Inflarx Nv Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: IFRX) stock is to Strong Buy IFRX stock.

Out of 5 analysts, 3 (60%) are recommending IFRX as a Strong Buy, 2 (40%) are recommending IFRX as a Buy, 0 (0%) are recommending IFRX as a Hold, 0 (0%) are recommending IFRX as a Sell, and 0 (0%) are recommending IFRX as a Strong Sell.

If you're new to stock investing, here's how to buy Inflarx Nv stock.

What is IFRX's earnings growth forecast for 2026-2028?

(NASDAQ: IFRX) Inflarx Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.22%.

Inflarx Nv's earnings in 2026 is -$45,097,482.On average, 9 Wall Street analysts forecast IFRX's earnings for 2026 to be -$41,012,576, with the lowest IFRX earnings forecast at -$46,214,674, and the highest IFRX earnings forecast at -$37,136,792. On average, 9 Wall Street analysts forecast IFRX's earnings for 2027 to be -$51,962,035, with the lowest IFRX earnings forecast at -$67,877,803, and the highest IFRX earnings forecast at -$40,231,524.

In 2028, IFRX is forecast to generate -$67,140,961 in earnings, with the lowest earnings forecast at -$98,206,182 and the highest earnings forecast at -$46,420,990.

What is IFRX's revenue growth forecast for 2026-2028?

(NASDAQ: IFRX) Inflarx Nv's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.

Inflarx Nv's revenue in 2026 is -$11,637.On average, 9 Wall Street analysts forecast IFRX's revenue for 2026 to be $0, with the lowest IFRX revenue forecast at $0, and the highest IFRX revenue forecast at $0. On average, 9 Wall Street analysts forecast IFRX's revenue for 2027 to be $0, with the lowest IFRX revenue forecast at $0, and the highest IFRX revenue forecast at $0.

In 2028, IFRX is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is IFRX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: IFRX) forecast ROA is -34.92%, which is lower than the forecast US Biotechnology industry average of 23.75%.

What is IFRX's Price Target?

According to 5 Wall Street analysts that have issued a 1 year IFRX price target, the average IFRX price target is $9.00, with the highest IFRX stock price forecast at $14.00 and the lowest IFRX stock price forecast at $6.00.

On average, Wall Street analysts predict that Inflarx Nv's share price could reach $9.00 by Sep 14, 2027. The average Inflarx Nv stock price prediction forecasts a potential upside of 330.62% from the current IFRX share price of $2.09.

What is IFRX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: IFRX) Inflarx Nv's current Earnings Per Share (EPS) is -$0.58. On average, analysts forecast that IFRX's EPS will be -$0.28 for 2026, with the lowest EPS forecast at -$0.31, and the highest EPS forecast at -$0.25. On average, analysts forecast that IFRX's EPS will be -$0.35 for 2027, with the lowest EPS forecast at -$0.46, and the highest EPS forecast at -$0.27. In 2028, IFRX's EPS is forecast to hit -$0.46 (min: -$0.67, max: -$0.32).

What is IFRX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: IFRX) forecast ROE is -39.87%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.